News

The joint effort will focus on providing patients with medication guidance, reminders, tracking of efficacy and health education.
One in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.
Key Points Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street.However, the company ...
Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of ...
A study reveals potentially fatal side effects of GLP-1 drugs, that people are using to lose weight. It’s well known that ...
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...